Gut-targeted Type 2 diabetes therapy for patients with chronic kidney disease.
Anji is agnostic to technology and modality. We care most about pursuing drug targets with the greatest potential to improve lives, as efficiently as possible.
Our name was inspired by the Anji Bridge (Zhaozhou Bridge), one of the oldest stone-arch bridges in the world. Anji translates to “safe crossing” and “to aid those in need.” Our biotech company bridges science and culture to deliver safe and effective medicines to patients who need them most.
Anji was built with a fervent desire to improve lives. Our pedigreed team blends deep drug development know-how with an unwavering resolve to get things done. Rather than focusing on what’s trendy, we focus on what works.
Anji Pharma Launches Phase 3 Trial for ANJ900 to Treat Type 2 Diabetes Patients with Kidney Disease
We’ve provided additional information and resources to untangle the diseases we aim to treat.